Nothing Special   »   [go: up one dir, main page]

Latest News for: phase 2 clinical trial

Edit

The Motley Fool: Not-so-bad cinical trial results

The Spokesman-Review 02 Feb 2025
AMGN) started crashing in early November and didn’t improve when the company released data from a phase 2 clinical trial for its weight-loss candidate MariTide ... results to data from clinical trials.
Edit

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

Knoxville Daily Sun 01 Feb 2025
Defendants further discussed the potential for a second Phase 2 clinical trial combining azelaprag and semaglutide to treat obesity in individuals ages 18 years and older.
Edit

Cough in Idiopathic Pulmonary Fibrosis Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed ...

GetNews 31 Jan 2025
Emerging Cough in Idiopathic Pulmonary Fibrosis therapies in the different phases of clinical trials are - Orvepitant Maleate, Haduvio (nalbuphine ER), ME-015 (Suplatast Tosilate) BI 1839100, and ...
Edit

Musculoskeletal Pain Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | ...

GetNews 31 Jan 2025
Emerging Musculoskeletal Pain therapies in the different phases of clinical trials are- MPC-06-ID, Fasinumab, TLC599, Eli Lilly, AXS-14, Lorecivivint, CNTX-4975, X0002, and others are expected to have ...
Edit

Chronic Rhinosinusitis with Nasal Polyps Pipeline 2024: FDA Approvals and Clinical Trials Landscape with MOA ...

GetNews 31 Jan 2025
Emerging Chronic Rhinosinusitis with Nasal Polyps therapies in the different phases of clinical trials are- NUCALA (mepolizumab), TEZSPIRE (tezepelumab), FASENRA (benralizumab), Tezepelumab, CM310, ...
Edit

IMCAS 2025: New Galderma Phase Iiib Data Reinforce Rapid Onset And Long-Lasting Aesthetic Improvement With Relabotulinum

MENA FN 31 Jan 2025
(MENAFN - AETOSWire) (BUSINESS WIRE )--Galderma (SWX.GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid ... .
Edit

Cleveland Clinic Abu Dhabi collaborates with BioTwin

GCC Business News 31 Jan 2025
BioTwin’s partnership with Cleveland Clinic Abu Dhabi aims to validate this cutting-edge technology which is currently in its trial phase by creating unique patient profiles for breast cancer ...
Edit

FDA approves new class of painkiller – the first in more than 20 years

New Atlas 31 Jan 2025
At the beginning of 2024, New Atlas covered the impressive results of Phase 3 clinical trials by Vertex Pharmaceuticals Inc ... Vertex is currently undertaking Phase 3 trials to evaluate suzetrigine’s ...
Edit

Chronic Obstructive Pulmonary Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | Genentech, GlaxoSmithKline, ...

GetNews 31 Jan 2025
... patient in its Phase 2a proof-of-concept (“POC”) clinical trial of fexlamose (previously known as “AER-01”) for Chronic Obstructive Pulmonary Disease (“COPD”).
Edit

FDA approves new type of nonopioid painkiller for acute pain

NBC Bay Area 31 Jan 2025
In phase 3 clinical trials by the drugmaker, researchers looked at how well the drug worked after surgery ... Vertex isn’t pursuing the FDA’s approval for suzetrigine to treat chronic pain — a phase ...
Edit

Epirium Bio Announces First Participants Dosed in Phase 1 Clinical Trial in Healthy Volunteers, Evaluating ...

Business Wire 30 Jan 2025
(Epirium), a biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, ...
Edit

Extensive-Stage SCLC Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by ...

GetNews 30 Jan 2025
Emerging Extensive-Stage Small Cell Lung Cancer therapies in the different phases of clinical trials are- RP12146, SYHA1807, BNT411, Bomedemstat, AK104, QL1706, Tarlatamab, Socazolimab, Tislelizumab, ...
Edit

Mucopolysaccharidosis Type III Pipeline 2024: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by ...

GetNews 30 Jan 2025
Emerging Mucopolysaccharidosis Type III therapies in the different phases of clinical trials are JWK-008 Chengdu, Research programme ... (TSE 4552, JCR) have announced the commencement of a Phase I/II ...
Edit

Ischemic Stroke Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | ...

GetNews 30 Jan 2025
In January 2024, Aruna Bio revealed intentions to commence a Phase I/II clinical trial of AB126 for treating acute ischemic stroke by the first half of 2024.
Edit

Triple Negative Breast Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight

GetNews 30 Jan 2025
Currently the drug is in Phase III stage of Clinical trial evaluation for the treatment of Triple Negative Breast Cancer ... Currently, the drug is in Phase II stage of clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

Most Viewed

×